Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prediction and prevention of infantile spasms in high-risk infants using vigabatrin
2024-517488-22-00Phase 4Authorised
- Sponsor
- Helsinki University Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of vigabatrin in West syndrome, sponsored by Helsinki University Hospital. Primary endpoint: Occurrence of infantile spasm syndrome. Planned start Sep 2024; status: authorised.
02
Drugs
vigabatrin
03
Conditions
West syndrome
Beyond the preview
Go deeper on 2024-517488-22-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517488-22-00.